Crystallin-Derived Anti-Chaperones in the Lens
晶状体中的晶状体蛋白衍生的反伴侣分子
基本信息
- 批准号:8306862
- 负责人:
- 金额:$ 36.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2014-08-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAgeAgingBinding SitesBiochemicalBlindnessCataractCaviaCell NucleusCellsCleaved cellComplexCrystallinsDiseaseGenerationsGoalsHealthHumanHydrogen PeroxideHyperbaric OxygenIn VitroLeadLens OpacitiesMass Spectrum AnalysisMeasuresMediatingMethodsMindModelingMolecularMolecular ChaperonesMolecular WeightNuclearPeptide HydrolasesPeptidesPhysical condensationPrecipitationPredispositionPropertyProteinsProteolysisReactionRelative (related person)RoleSamplingSenile CataractSiteSpatial DistributionSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStructureSystems AnalysisTechniquesTestingTimeToxic effectWaterage relatedagedanalytical toolin vivoinhibitor/antagonistlenslens proteinlens transparencymethod developmentnovelpreventprotein aggregateprotein aggregationprotein structureyoung adult
项目摘要
DESCRIPTION (provided by applicant): Changes in the structure of crystallins, the major lens protein, are thought to account for the loss of lens transparency that occurs with aging. Aged and cataractous human lenses show increased crystallin proteolysis and aggregation as compared to young, non-cataractous lenses. However, the molecular mechanisms for age-related protein aggregation are not fully understood. We hypothesize that protein aggregation in the aging lens (>40 years old) is initiated by the actions of novel proteases, which recognize a specific sequence in crystallins and are responsible for cleavage of crystallin and generation of crystallin fragments with anti-chaperone activity and toxic properties. The crystallin fragments with anti-chaperone activity interact with 1A- and 1B-crystallins at chaperone sites, contributing to the loss of the 1-crystallin chaperone activity known to occur in aged, less transparent lenses and cataractous lenses. Additionally the interactions between crystallin fragments and intact, modified or truncated crystallins lead to age-related protein aggregation and insolubilization of 1-crystallin in the nuclear region of the lens, resulting in loss of transparency and cataract formation. In support of our hypothesis that crystallin-derived anti-chaperone peptides have a key role in the age-related loss of lens transparency, we have demonstrated that in vivo-generated human lens crystallin fragments generate H2O2, display anti-chaperone activity and induce lens protein aggregation and precipitation. Studies will be performed in both human lenses and in the guinea pig model of age-related cataractogenesis. We propose to undertake studies to identify the origin of crystallin fragments and to characterize the proteolytic mechanisms responsible for the cleavage of crystallins and the generation of anti-chaperone peptides. Using state-of-the-art mass spectrometric tools and analytical techniques, we will expand our understanding of the molecular mechanisms involved in crystallin-derived-peptide mediated protein aggregation and cataractogenesis. The proposed studies will accomplish the following Specific Aims: 1) Investigate the low-molecular weight crystallin fragments present in young, adult, aged and cataractous human lenses and in lenses of normal and hyperbaric oxygen (HBO)-treated guinea pigs. 2) Characterize the crystallin-derived anti-chaperone peptides and determine their ability to induce 1- crystallin aggregation in vitro and ex vivo. 3) Investigate whether sequence-specific proteases or non-enzymatic cleavages are responsible for the generation of crystallin-derived anti-chaperone peptides and isolate and characterize the novel protease involved.
PUBLIC HEALTH RELEVANCE: Understanding why the lens so commonly develops a cataract may lead to the development of methods for preventing this common cause of vision loss. During aging, for some unknown reason, the lens begins to accumulate peptides (breakdown products) derived from crystallin (peptides), the major protein in the lens. Over time, these peptides become toxic in the lens as they accumulate, leading to loss of lens transparency and cataract.
性状(由申请方提供):认为晶体蛋白(主要透镜蛋白)结构的变化是老化导致透镜透明度丧失的原因。与年轻的非白内障晶状体相比,老年和白内障的人晶状体显示出增加的晶状体蛋白水解和聚集。然而,与年龄相关的蛋白质聚集的分子机制尚未完全了解。我们推测,老化透镜(>40岁)中的蛋白质聚集是由新型蛋白酶的作用引发的,这些蛋白酶识别晶状体蛋白中的特定序列,并负责切割晶状体蛋白和产生具有抗分子伴侣活性和毒性特性的晶状体蛋白片段。具有抗分子伴侣活性的晶状体蛋白片段在分子伴侣位点与1A-和1B-晶状体蛋白相互作用,导致已知在老化、不太透明的晶状体和白内障晶状体中发生的1-晶状体蛋白分子伴侣活性丧失。此外,晶状体蛋白片段与完整的、修饰的或截短的晶状体蛋白之间的相互作用导致与年龄相关的蛋白质聚集和1-晶状体蛋白在透镜的核区域中的不溶解,导致透明度丧失和白内障形成。为了支持我们的假设,即堆叠衍生的抗分子伴侣肽在与年龄相关的透镜透明度丧失中具有关键作用,我们已经证明了体内产生的人透镜晶状体蛋白片段产生H2 O2,显示抗分子伴侣活性并诱导透镜蛋白聚集和沉淀。将在人类晶状体和年龄相关性白内障发生的豚鼠模型中进行研究。我们建议进行研究,以确定晶体蛋白片段的起源,并表征负责晶体蛋白的切割和抗伴侣肽的产生的蛋白水解机制。使用国家的最先进的质谱工具和分析技术,我们将扩大我们的理解的分子机制参与堆叠衍生肽介导的蛋白质聚集和白内障。1)研究年轻人、成年人、老年人和白内障患者晶状体以及正常豚鼠和高压氧(HBO)处理豚鼠晶状体中存在的低分子量晶状体蛋白片段。2)表征堆叠衍生的抗分子伴侣肽,并确定其在体外和离体诱导1-晶状体蛋白聚集的能力。3)研究序列特异性蛋白酶或非酶裂解是否负责产生堆叠衍生的抗分子伴侣肽,并分离和表征所涉及的新型蛋白酶。
公共卫生相关性:了解为什么透镜如此普遍地发展白内障可能导致预防这种常见原因的视力丧失的方法的发展。在老化过程中,由于某些未知的原因,透镜开始积累源自晶体蛋白(肽)的肽(分解产物),晶体蛋白是透镜中的主要蛋白质。随着时间的推移,这些肽在透镜中积累时变得有毒,导致透镜透明度丧失和白内障。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KRISHNA K SHARMA其他文献
KRISHNA K SHARMA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KRISHNA K SHARMA', 18)}}的其他基金
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
- 批准号:
8470982 - 财政年份:2013
- 资助金额:
$ 36.2万 - 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
- 批准号:
9132472 - 财政年份:2013
- 资助金额:
$ 36.2万 - 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
- 批准号:
10200048 - 财政年份:2013
- 资助金额:
$ 36.2万 - 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
- 批准号:
8841373 - 财政年份:2013
- 资助金额:
$ 36.2万 - 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
- 批准号:
10657220 - 财政年份:2013
- 资助金额:
$ 36.2万 - 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
- 批准号:
9265858 - 财政年份:2013
- 资助金额:
$ 36.2万 - 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
- 批准号:
8657443 - 财政年份:2013
- 资助金额:
$ 36.2万 - 项目类别:
Metastable Crystallins: Structure and Stabilization
亚稳态晶体蛋白:结构和稳定性
- 批准号:
9769023 - 财政年份:2013
- 资助金额:
$ 36.2万 - 项目类别:
Crystallin-Derived Mini-Chaperones as Protein Aggregation Inhibitors
晶状体蛋白衍生的微型伴侣作为蛋白质聚集抑制剂
- 批准号:
7976444 - 财政年份:2010
- 资助金额:
$ 36.2万 - 项目类别:
Crystallin-Derived Anti-Chaperones in the Lens
晶状体中的晶状体蛋白衍生的反伴侣分子
- 批准号:
7992774 - 财政年份:2010
- 资助金额:
$ 36.2万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 36.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 36.2万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 36.2万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 36.2万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 36.2万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 36.2万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 36.2万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 36.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 36.2万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 36.2万 - 项目类别:
Operating Grants